{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:04:38Z","timestamp":1772121878598,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/s1474-4422(09)70139-5","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T05:59:16Z","timestamp":1244699956000},"page":"619-627","source":"Crossref","is-referenced-by-count":443,"title":["Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study"],"prefix":"10.1016","volume":"8","author":[{"given":"Pieter Jelle","family":"Visser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk L","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-Olof","family":"Wahlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Freund-Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Tsolaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa K","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"B\u00fcrger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuula","family":"Pirttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilkka","family":"Soininen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel Olde","family":"Rikkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel M","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiza","family":"Spiru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(09)70139-5_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib3","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(09)70139-5_bib4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid (beta)-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000135644","article-title":"Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA study","volume":"30","author":"Visser","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d, a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S1474-4422(09)70139-5_bib7","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(09)70139-5_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S1474-4422(09)70139-5_bib10","series-title":"Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clinical gerontology: a guide to assessment and intervention","first-page":"165","author":"Sheikh","year":"1986"},{"key":"10.1016\/S1474-4422(09)70139-5_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","article-title":"Cornell scale for depression in dementia","volume":"23","author":"Alexopoulos","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S1474-4422(09)70139-5_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1017\/S1355617705050344","article-title":"Rey's verbal learning test: normative data for 1855 healthy participants aged 24\u201381 years and the influence of age, sex, education, and mode of presentation","volume":"11","author":"Van der Elst","year":"2005","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/S1474-4422(09)70139-5_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.44.4.609","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD). Part V. A normative study of the neuropsychological battery","volume":"44","author":"Welsh","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1017\/S1355617706060115","article-title":"Normative data for the animal, profession and letter naming verbal fluency tests for Dutch-speaking participants and the effects of age, education, and sex","volume":"12","author":"Van der Elst","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/S1474-4422(09)70139-5_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indication of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"10.1016\/S1474-4422(09)70139-5_bib16","first-page":"286","article-title":"L'examen psychologie dans les cas d'encephalopathie traumatique","volume":"28","author":"Rey","year":"1941","journal-title":"Archives de Psychologie"},{"key":"10.1016\/S1474-4422(09)70139-5_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1\u201342) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(99)00617-5","article-title":"Cerebrospinal fluid tau and A-beta-42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment","volume":"273","author":"Andreasen","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/S1474-4422(09)70139-5_bib19","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archneur.59.11.1729","article-title":"Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment","volume":"59","author":"Riemenschneider","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/01.WNL.0000156914.16988.56","article-title":"CSF A(beta)42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment","volume":"64","author":"Herukka","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(09)70139-5_bib22","first-page":"111","article-title":"The telephone interview for cognitive status","volume":"1","author":"Brandt","year":"1988","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib23","series-title":"Diagnostic and statistical manual of mental disorders","year":"1994"},{"key":"10.1016\/S1474-4422(09)70139-5_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS\u2013ADRDA work-group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS\u2013AIREN international workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/S1474-4422(09)70139-5_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B"},{"key":"10.1016\/S1474-4422(09)70139-5_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jnnp.73.2.126","article-title":"Visual association test to detect early dementia of the Alzheimer type","volume":"73","author":"Lindeboom","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(09)70139-5_bib32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/13803390490515540","article-title":"Three-word recall in normal aging","volume":"26","author":"Chandler","year":"2004","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib33","series-title":"A compendium of neuropsychological tests","author":"Spreen","year":"1998"},{"key":"10.1016\/S1474-4422(09)70139-5_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J Exp Psychol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib35","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(09)70139-5_bib36","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00415-008-0897-4","article-title":"Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study","volume":"255","author":"Nobili","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1159\/000167880","article-title":"Differential hypometabolism patterns according to mild cognitive impairment subtypes","volume":"26","author":"Jauhiainen","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/S1474-4422(09)70139-5_bib38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archneur.64.8.1130","article-title":"Patterns of atrophy differ among specific subtypes of mild cognitive impairment","volume":"64","author":"Whitwell","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0306-4522(95)00014-A","article-title":"Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes","volume":"67","author":"Lehtovirta","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/S1474-4422(09)70139-5_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","article-title":"High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype","volume":"55","author":"Galasko","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/brain\/123.3.484","article-title":"Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases","volume":"123","author":"Galton","year":"2000","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(09)70139-5_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000105017","article-title":"Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly","volume":"24","author":"Stomrud","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/S1474-4422(09)70139-5_bib45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archneurol.2008.511","article-title":"Carbon 11-labeled Pittsburgh compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease","volume":"66","author":"Wiley","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(09)70139-5_bib47","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1212\/01.wnl.0000286944.22262.ff","article-title":"Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI","volume":"69","author":"Ewers","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib48","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.wnl.0000256043.50901.e3","article-title":"Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker","volume":"68","author":"Bateman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(09)70139-5_bib49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS\u2013ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442209701395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442209701395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T21:53:44Z","timestamp":1739138024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442209701395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1474442209701395"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(09)70139-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1166395.627365","asserted-by":"object"}]},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}